|
|
|
|
Receive the latest news from the brand
protection world, direct to your in box! |
||
| SUBSCRIBE | ||
|
|
08.08.2007
The EPO intends to issue Opexa patent for “Autologous T Cell Vaccine Materials and Method,” a unique method-specific approach for generating a T-cell vaccine that attacks what is believed to be the underlying cause of multiple sclerosis (MS).
|
|
30.07.2007
The EC has decided to open formal anti-trust proceedings against the German E.ON and the French Gaz de France for a suspected breach of the EC Treaty's rules on restrictive business practices.
|
|
30.07.2007
The EPO, the DPMA and the UK-IPO, have published an independent study which benchmarks productivity in the patent grant procedure at the three offices.
|
|
30.07.2007
The final purchase price for the acquisition was $15.3 million.
|
Newer << < 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | > >> Older
|
|
|||
| About Us | Online Policies | Contact Us | Membership | Media Kit | Press Releases | Editorial Info | Reprints | Site Map |  |
| Copyright © BPCouncil 2007. All rights reserved. |
Created by
 |
|||||||||||